The newly introduced ZEISS Volutome is an in-chamber ultramicrotome for ZEISS field emission scanning electron microscopes (FE-SEM). It is designed to imag...
Agilent Technologies Inc. (NYSE: A) announces the 10th anniversary of the Agilent BioTek Cytation 3 cell imaging multimode reader and the Agilent Bio...
The Consumer Health Division of Bayer has launched a business unit focused on developing new Precision Health products across its range of everyday health ...
Responds to global demand for biosafety testing for drug development and commercialization Expansion creates nearly 500 new jobs in Glasgow and Stirling...
Stéphane Rohan Laurent, Capnopharm’s VP Sales & Business Development, comments: “Receiving CE certification constitutes a landm...
This strategic partnership represents a significant milestone in Synexa's commitment to global health security and its dedication to fostering collaboratio...
SKYCovion is the world’s first-ever vaccine developed using the RoseTTAFold, a software tool that uses deep learning. SK bioscience has appl...
Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, announced that Nuvaxovid&tra...
— Prescription Drug User Fee Act (PDUFA) Target Action Date set for November 30, 2023 — — NDA includes results from the Phase III FRESCO...
Veeva Systems (NYSE: VEEV) announced that leaders from Bayer, Boehringer Ingelheim, GSK, LEO Pharma, Recordati, and Syneos Health are among the speak...
Beren is a vertically integrated biopharmaceutical company focused on addressing the world’s most significant health challenges. Roquette recognizes ...
Humanetics Biomed is a Contract Development Manufacturing Organisation (CDMO) that combines the best biomedical technologies from Humanetics; with the tech...
“We are thrilled to partner with BeiGene to help people living with CLL in low- and middle-income countries have access to BRUKINSA,” said Pat ...
© 2025 Biopharma Boardroom. All Rights Reserved.
